Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/67140
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: OCT-1 as a determinant of response to antileukemic treatment
Author: Engler, J.
Hughes, T.
White, D.
Citation: Clinical Pharmacology & Therapeutics, 2011; 89(4):608-611
Publisher: Mosby Inc
Issue Date: 2011
ISSN: 0009-9236
1532-6535
Statement of
Responsibility: 
JR Engler, TP Hughes and DL White
Keywords: Humans; Leukemia, Myeloid, Chronic-Phase; Benzamides; Piperazines; Pyrimidines; Organic Cation Transporter 1; Antineoplastic Agents; Protein Kinase Inhibitors; Drug Resistance, Neoplasm; Imatinib Mesylate
Rights: © 2011 American Society for Clinical Pharmacology and Therapeutics
RMID: 0020104820
DOI: 10.1038/clpt.2011.12
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.